307 related articles for article (PubMed ID: 31113713)
1. Rural risk environments for hepatitis c among young adults in appalachian kentucky.
Cloud DH; Ibragimov U; Prood N; Young AM; Cooper HLF
Int J Drug Policy; 2019 Oct; 72():47-54. PubMed ID: 31113713
[TBL] [Abstract][Full Text] [Related]
2. Prescription opioid injection among young people who inject drugs in New York City: a mixed-methods description and associations with hepatitis C virus infection and overdose.
Mateu-Gelabert P; Guarino H; Zibbell JE; Teubl J; Fong C; Goodbody E; Edlin B; Salvati C; Friedman SR
Harm Reduct J; 2020 Mar; 17(1):22. PubMed ID: 32228700
[TBL] [Abstract][Full Text] [Related]
3. Factors that influence enrollment in syringe services programs in rural areas: a qualitative study among program clients in Appalachian Kentucky.
Ibragimov U; Cooper KE; Batty E; Ballard AM; Fadanelli M; Gross SB; Klein EM; Lockard S; Young AM; Cooper HLF
Harm Reduct J; 2021 Jun; 18(1):68. PubMed ID: 34193165
[TBL] [Abstract][Full Text] [Related]
4. People, places, and stigma: A qualitative study exploring the overdose risk environment in rural Kentucky.
Fadanelli M; Cloud DH; Ibragimov U; Ballard AM; Prood N; Young AM; Cooper HLF
Int J Drug Policy; 2020 Nov; 85():102588. PubMed ID: 31753603
[TBL] [Abstract][Full Text] [Related]
5. A qualitative analysis of rural syringe service program fidelity in Appalachian Kentucky: Staff and participant perspectives.
Batty EJ; Ibragimov U; Fadanelli M; Gross S; Cooper K; Klein E; Ballard AM; Young AM; Lockard AS; Oser CB; Cooper HLF
J Rural Health; 2023 Mar; 39(2):328-337. PubMed ID: 36117151
[TBL] [Abstract][Full Text] [Related]
6. Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users.
Havens JR; Lofwall MR; Frost SD; Oser CB; Leukefeld CG; Crosby RA
Am J Public Health; 2013 Jan; 103(1):e44-52. PubMed ID: 23153148
[TBL] [Abstract][Full Text] [Related]
7. HIV- and hepatitis C-related risk behaviors among people who inject drugs in Uganda: implications for policy and programming.
Baluku M; Wamala T; Muhangi D
Harm Reduct J; 2019 Sep; 16(1):56. PubMed ID: 31481086
[TBL] [Abstract][Full Text] [Related]
8. Community Perceptions of Comprehensive Harm Reduction Programs and Stigma Towards People Who Inject Drugs in Rural Virginia.
Baker LS; Smith W; Gulley T; Tomann MM
J Community Health; 2020 Apr; 45(2):239-244. PubMed ID: 31502098
[TBL] [Abstract][Full Text] [Related]
9. Kentucky Outreach Service Kiosk (KyOSK) Study protocol: a community-level, controlled quasi-experimental, type 1 hybrid effectiveness study to assess implementation, effectiveness and cost-effectiveness of a community-tailored harm reduction kiosk on HIV, HCV and overdose risk in rural Appalachia.
Young AM; Havens JR; Cooper HLF; Fallin-Bennett A; Fanucchi L; Freeman PR; Knudsen H; Livingston MD; McCollister KE; Stone J; Vickerman P; Freeman E; Jahangir T; Larimore E; White CR; Cheatom C; Community Staff K; Design Team K
BMJ Open; 2024 Mar; 14(3):e083983. PubMed ID: 38431295
[TBL] [Abstract][Full Text] [Related]
10. Novel Recruitment Methods for Research Among Young Adults in Rural Areas Who Use Opioids: Cookouts, Coupons, and Community-Based Staff.
Young AM; Ballard AM; Cooper HLF
Public Health Rep; 2020; 135(6):746-755. PubMed ID: 32933438
[TBL] [Abstract][Full Text] [Related]
11. Disparities in risk perception and low harm reduction services awareness, access, and utilization among young people with newly reported hepatitis C infections in California, 2018.
Ohringer AR; Serota DP; McLean RL; Stockman LJ; Watt JP
BMC Public Health; 2021 Jul; 21(1):1435. PubMed ID: 34289822
[TBL] [Abstract][Full Text] [Related]
12. Barriers and facilitators of HIV and hepatitis C care among people who inject drugs in Nairobi, Kenya: a qualitative study with peer educators.
Ludwig-Barron NT; Guthrie BL; Mbogo L; Bukusi D; Sinkele W; Gitau E; Farquhar C; Monroe-Wise A
Harm Reduct J; 2021 Dec; 18(1):133. PubMed ID: 34922548
[TBL] [Abstract][Full Text] [Related]
13. Who goes first? Understanding hepatitis C risk among injecting networks in the prison setting.
Lafferty L; Rance J; Treloar C
Drug Alcohol Depend; 2018 Feb; 183():96-101. PubMed ID: 29245104
[TBL] [Abstract][Full Text] [Related]
14. Viral hepatitis and injection drug use in Appalachian Kentucky: a survey of rural health department clients.
Christian WJ; Hopenhayn C; Christian A; McIntosh D; Koch A
Public Health Rep; 2010; 125(1):121-8. PubMed ID: 20402204
[TBL] [Abstract][Full Text] [Related]
15. Healthcare contact and treatment uptake following hepatitis C virus screening and counseling among rural Appalachian people who use drugs.
Stephens DB; Young AM; Havens JR
Int J Drug Policy; 2017 Sep; 47():86-94. PubMed ID: 28648353
[TBL] [Abstract][Full Text] [Related]
16. Predictors of engagement in screening for a hepatitis C virus (HCV) treatment trial in a rural Appalachian community.
Havens JR; Lofwall MR; Young AM; Staton M; Schaninger T; Fraser H; Vickerman P; Walsh SL
J Viral Hepat; 2024 Jun; 31(6):293-299. PubMed ID: 38436098
[TBL] [Abstract][Full Text] [Related]
17. A qualitative study on pharmacy policies toward over-the-counter syringe sales in a rural epicenter of US drug-related epidemics.
Fadanelli M; Cooper HLF; Freeman PR; Ballard AM; Ibragimov U; Young AM
Harm Reduct J; 2022 Jan; 19(1):1. PubMed ID: 34996466
[TBL] [Abstract][Full Text] [Related]
18. Access to and use of health and social services among people who inject drugs in two urban areas of Mozambique, 2014: qualitative results from a formative assessment.
Dengo-Baloi L; Boothe M; Semá Baltazar C; Sathane I; Langa DC; Condula M; Ricardo H; Inguane C; Teodoro E; Gouveia L; Raymond HF; Horth R
BMC Public Health; 2020 Jun; 20(1):975. PubMed ID: 32571365
[TBL] [Abstract][Full Text] [Related]
19. Correlates of anti-hepatitis C positivity and use of harm reduction services among people who inject drugs in two cities in Croatia.
Handanagic S; Sevic S; Barbaric J; Dominkovic Z; Dakovic Rode O; Begovac J; Bozicevic I
Drug Alcohol Depend; 2017 Feb; 171():132-139. PubMed ID: 28088084
[TBL] [Abstract][Full Text] [Related]
20. "We don't need services. We have no problems": exploring the experiences of young people who inject drugs in accessing harm reduction services.
Krug A; Hildebrand M; Sun N
J Int AIDS Soc; 2015; 18(2 Suppl 1):19442. PubMed ID: 25724510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
